MMP2 and MMP9 Contribute to Lung Ischemia-reperfusion Injury Via Promoting Pyroptosis in Mice

Overview

Journal BMC Pulm Med

Publisher Biomed Central

Specialty Pulmonary Medicine

Date 2022 Jun 15

PMID 35705936

Authors

Peng Zhou

Nai-Cheng Song

Zhi-Kun Zheng

Yi-Qing Li

Jin-Song Li

Affiliations

Soon will be listed here.

Abstract

Background: Lung ischemia-reperfusion injury (LIRI) is a cause of poor prognosis in several lung diseases and after lung transplantation. In LIRI, matrix metalloproteinases and pyroptosis indicators change in parallel, both of them involvement of inflammatory modulation, but it is unclear whether they are related to each other.

Methods: We analyzed the matrix metalloproteinases (MMPs) changes from RNA sequencing (RNA-Seq) data of human transplantation and rat ischemia-reperfusion lung tissues in the Group on Earth Observations (GEO) database. Then established the mouse LIRI model to validate the changes. Further, the severity of lung injury was measured after intervening the matrix metalloproteinases changes with their selective inhibitor during Lung ischemia-reperfusion. Meanwhile, lung, pyroptosis was assessed by assaying the activity of Caspase-1 and interleukin 1β (IL-1β) before and after intervening the matrix metalloproteinases changes.

Results: The RNA-Seq data revealed that matrix metallopeptidase 2 (MMP2), matrix metallopeptidase 9 (MMP9) mRNA expression was elevated both in human lung transplantation and rat lung ischemia-reperfusion tissues, consistent with the change in our mouse model. At the same time, the activity of Caspase-1 and IL-1β were increased after LIRI. While, the lung injury was attenuated for the use of MMP2 and MMP9 selective inhibitor SB-3CT. Likewise, lung pyroptosis alleviated when treatment the mice with SB-3CT in LIRI.

Conclusion: We conclude that MMP2 and MMP9 are involved in the process of LIRI, the mechanism of which is related to the promotion of lung pyroptosis.

Citing Articles

Chaihuang Qingfu Pills Protect Against Acute Pancreatitis-Associated Acute Lung Injury Through MMP9-NLRP3-Pyroptosis Pathway.

Xiao W, Shi H, Tian Y, Chen F, Xie Y, Han X J Inflamm Res. 2025; 18:2317-2338.

PMID: 39991664 PMC: 11846512. DOI: 10.2147/JIR.S501531.

Intraoperative Use of Sodium Bicarbonate Ringer's Solution Instead of Sodium Lactate Ringer's Solution to Reduce Endothelial Glycocalyx Degradation and Improve Postoperative Recovery During Cardiopulmonary Bypass Cardiac Surgery: A Single-Center....

Shi Y, Shi Y, Tao Y, Xu B, Wang X, Xie Y Drug Des Devel Ther. 2024; 18:5881-5893.

PMID: 39679133 PMC: 11645961. DOI: 10.2147/DDDT.S501657.

Luteolin alleviates cerebral ischemia/reperfusion injury by regulating cell pyroptosis.

Yu F, Wang G, Chen X, Zhang Y, Yang C, Hu H Open Med (Wars). 2024; 19(1):20241063.

PMID: 39507105 PMC: 11538924. DOI: 10.1515/med-2024-1063.

Improving lung allograft function in the early post-operative period through the inhibition of pyroptosis.

Gouchoe D, Zhang Z, Kim J, Lee Y, Whitson B, Zhu H Med Rev (2021). 2024; 4(5):384-394.

PMID: 39444796 PMC: 11495470. DOI: 10.1515/mr-2023-0066.

Identification of PANoptosis-related genes for idiopathic pulmonary fibrosis by machine learning and molecular subtype analysis.

Wu L, Liu Y, Zhang Y, Xu R, Bi K, Li J Sci Rep. 2024; 14(1):24068.

PMID: 39402203 PMC: 11473738. DOI: 10.1038/s41598-024-76263-7.

References

Soccal P, Gasche Y, Pache J, Schneuwly O, Slosman D, Morel D . Matrix metalloproteinases correlate with alveolar-capillary permeability alteration in lung ischemia-reperfusion injury. Transplantation. 2000; 70(7):998-1005. DOI: 10.1097/00007890-200010150-00002. View

Xu Y, Niu Y, Li H, Pan G . Downregulation of lncRNA TUG1 attenuates inflammation and apoptosis of renal tubular epithelial cell induced by ischemia-reperfusion by sponging miR-449b-5p via targeting HMGB1 and MMP2. Inflammation. 2020; 43(4):1362-1374. DOI: 10.1007/s10753-020-01214-z. View

den Hengst W, Gielis J, Lin J, Van Schil P, De Windt L, Moens A . Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological process. Am J Physiol Heart Circ Physiol. 2010; 299(5):H1283-99. DOI: 10.1152/ajpheart.00251.2010. View

Shi Y, Xu T, Li L, Chen X . Over-expression of VEGF and MMP-9 in residual tumor cells of hepatocellular carcinoma after embolization with lipidol. J Huazhong Univ Sci Technolog Med Sci. 2013; 33(1):90-95. DOI: 10.1007/s11596-013-1077-z. View

Bergsbaken T, Fink S, Cookson B . Pyroptosis: host cell death and inflammation. Nat Rev Microbiol. 2009; 7(2):99-109. PMC: 2910423. DOI: 10.1038/nrmicro2070. View

Cui J, Chen S, Zhang C, Meng F, Wu W, Hu R . Inhibition of MMP-9 by a selective gelatinase inhibitor protects neurovasculature from embolic focal cerebral ischemia. Mol Neurodegener. 2012; 7:21. PMC: 3500265. DOI: 10.1186/1750-1326-7-21. View

Esnault S, Kelly E, Johnson S, DeLain L, Haedt M, Noll A . Matrix Metalloproteinase-9-Dependent Release of IL-1 by Human Eosinophils. Mediators Inflamm. 2019; 2019:7479107. PMC: 6398033. DOI: 10.1155/2019/7479107. View

Yeh D, Lin H, Feng N, Chen C, Wang D, Wang N . Matrix metalloprotease expressions in both reperfusion lung injury and oleic acid lung injury models and the protective effects of ilomastat. Transplant Proc. 2009; 41(5):1508-11. DOI: 10.1016/j.transproceed.2009.02.076. View

Shimamoto A, Pohlman T, Shomura S, Tarukawa T, Takao M, Shimpo H . Toll-like receptor 4 mediates lung ischemia-reperfusion injury. Ann Thorac Surg. 2006; 82(6):2017-23. DOI: 10.1016/j.athoracsur.2006.06.079. View

10.

Roczkowsky A, Chan B, Lee T, Mahmud Z, Hartley B, Julien O . Myocardial MMP-2 contributes to SERCA2a proteolysis during cardiac ischaemia-reperfusion injury. Cardiovasc Res. 2019; 116(5):1021-1031. DOI: 10.1093/cvr/cvz207. View

11.

Liu H, Jing X, Dong A, Bai B, Wang H . Overexpression of TIMP3 Protects Against Cardiac Ischemia/Reperfusion Injury by Inhibiting Myocardial Apoptosis Through ROS/Mapks Pathway. Cell Physiol Biochem. 2017; 44(3):1011-1023. DOI: 10.1159/000485401. View

12.

Zhang J, Wang J, Zheng Z, Tang J, Fan K, Guo H . Participation of autophagy in lung ischemia-reperfusion injury in vivo. J Surg Res. 2012; 182(2):e79-87. DOI: 10.1016/j.jss.2012.11.014. View

13.

Zhaolin Z, Guohua L, Shiyuan W, Zuo W . Role of pyroptosis in cardiovascular disease. Cell Prolif. 2018; 52(2):e12563. PMC: 6496801. DOI: 10.1111/cpr.12563. View

14.

Fei L, Jingyuan X, Fangte L, Huijun D, Liu Y, Ren J . Preconditioning with rHMGB1 ameliorates lung ischemia-reperfusion injury by inhibiting alveolar macrophage pyroptosis via the Keap1/Nrf2/HO-1 signaling pathway. J Transl Med. 2020; 18(1):301. PMC: 7405465. DOI: 10.1186/s12967-020-02467-w. View

15.

Man S, Karki R, Kanneganti T . Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev. 2017; 277(1):61-75. PMC: 5416822. DOI: 10.1111/imr.12534. View

16.

Ng C, Wan S, Yim A, Arifi A . Pulmonary dysfunction after cardiac surgery. Chest. 2002; 121(4):1269-77. DOI: 10.1378/chest.121.4.1269. View

17.

Zhou P, Guo H, Li Y, Liu Q, Qiao X, Lu Y . Monocytes promote pyroptosis of endothelial cells during lung ischemia-reperfusion via IL-1R/NF-κB/NLRP3 signaling. Life Sci. 2021; 276:119402. DOI: 10.1016/j.lfs.2021.119402. View

18.

Yadav S, Kambis T, Kar S, Park S, Mishra P . MMP9 mediates acute hyperglycemia-induced human cardiac stem cell death by upregulating apoptosis and pyroptosis in vitro. Cell Death Dis. 2020; 11(3):186. PMC: 7070071. DOI: 10.1038/s41419-020-2367-6. View

19.

Zhou P, Yang C, Zhang S, Ke Z, Chen D, Li Y . The Imbalance of MMP-2/TIMP-2 and MMP-9/TIMP-1 Contributes to Collagen Deposition Disorder in Diabetic Non-Injured Skin. Front Endocrinol (Lausanne). 2021; 12:734485. PMC: 8579102. DOI: 10.3389/fendo.2021.734485. View

20.

Liu Z, Meng Y, Miao Y, Yu L, Yu Q . Propofol reduces renal ischemia/reperfusion-induced acute lung injury by stimulating sirtuin 1 and inhibiting pyroptosis. Aging (Albany NY). 2020; 13(1):865-876. PMC: 7834996. DOI: 10.18632/aging.202191. View